HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.

Abstract
Granulocyte colony-stimulating factor (G-CSF), a central mediator of the endogenous response to infection and inflammation, is approved for use in the prevention of infection-related complications in patients with nonmyeloid malignancies during antineoplastic therapy associated with high risk of severe neutropenia. Administration of granulocyte colony-stimulating factor results in improvement of host defence paired with anti-inflammatory effects. There is evidence from animal and clinical studies that administration of granulocyte colony-stimulating factor may also be beneficial in non-neutropenic infections. This review focuses mainly on the results of different animal and clinical studies of granulocyte colony stimulating factor used in the treatment of severe infections and sepsis.
AuthorsF J Wiedermann, M Mittermayr, G Hoffmann, W Schobersberger
JournalWiener klinische Wochenschrift (Wien Klin Wochenschr) Vol. 113 Issue 3-4 Pg. 90-6 (Feb 15 2001) ISSN: 0043-5325 [Print] Austria
PMID11253746 (Publication Type: Comparative Study, Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
  • Placebos
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim
Topics
  • Animals
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Bacterial Infections (drug therapy)
  • Brain Injuries (complications)
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor (administration & dosage, therapeutic use)
  • Guinea Pigs
  • Humans
  • Inflammation (drug therapy)
  • Mice
  • Neoplasms (drug therapy)
  • Neutropenia (drug therapy, etiology)
  • Placebos
  • Pneumonia, Bacterial (drug therapy)
  • Randomized Controlled Trials as Topic
  • Rats
  • Recombinant Proteins
  • Respiratory Distress Syndrome (complications)
  • Risk Factors
  • Sepsis (drug therapy, etiology)
  • Sheep
  • Shock, Hemorrhagic (drug therapy)
  • Shock, Septic (drug therapy)
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: